Oxybutynin 5 mg Immediate Release Tablets — Generic For Ditropan — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Oxybutynin chloride tablets are an antispasmodic, anticholinergic medicine taken by mouth. Each scored, round, uncoated tablet contains 5 mg of oxybutynin chloride.

The label says this medicine is used to help relieve symptoms of bladder instability linked to voiding in patients with uninhibited neurogenic or reflex neurogenic bladder. These symptoms include urgency, frequency, urinary leakage, urge incontinence, and dysuria.

The tablet works by relaxing bladder smooth muscle and helping reduce involuntary bladder contractions. The label also notes that it has been studied in adults and in pediatric patients age 5 years and older.

Storage Information

Store at 20° to 25°C (68° to 77°F); excursions permitted within 15°C to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in tight, light-resistant container as defined in the USP.

Key Counseling Points

• Take this medicine by mouth exactly as directed on the prescription label.
• This medicine may cause drowsiness or blurred vision; use caution with activities that require alertness.
• Alcohol may increase the drowsiness caused by oxybutynin.
• Common side effects reported on the label include dry mouth, constipation, dizziness, somnolence, blurred vision, nausea, and urinary retention.
• Seek urgent medical attention if swelling of the face, lips, tongue, or throat occurs, or if breathing becomes difficult.
• Tell a healthcare professional about other medicines you take, especially other anticholinergic drugs or medicines that can cause dry mouth, constipation, or drowsiness.
• Use caution if you have conditions noted on the label such as urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, or decreased gastrointestinal motility.
• The label says patients should be monitored for anticholinergic CNS effects such as hallucinations, agitation, confusion, or somnolence.
• The label warns about heat prostration due to decreased sweating in high environmental temperatures.
• If overdose is suspected, the label says treatment is symptomatic and supportive; emergency care is needed.

Helpful Patient Education

Oxybutynin chloride tablets, USP are oral antispasmodic, anticholinergic tablets containing 5 mg of oxybutynin chloride per scored, round tablet. According to the DailyMed label, they are indicated for relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder, including urgency, frequency, urinary leakage, urge incontinence, and dysuria.

Label information also describes common anticholinergic adverse effects such as dry mouth, constipation, dizziness, somnolence, and blurred vision, along with important warnings about angioedema, urinary retention, decreased gastrointestinal motility, and heat prostration. The product is supplied as white to off-white tablets and is for oral administration.

Medication Summary last generated: 2026-07-19 02:51:24